(Q44339195)

2 December 2017

title

The opioid antagonist naltrexone improves murine inflammatory bowel disease (English)

1 reference

inflammatory bowel diseases

2 December 2017

main subject

0 references

0 references

0 references

0 references

Gail L Matters

1

0 references

Jill P Smith

7

object named as

Jill P Smith

1 reference

2 December 2017

John F Harms

2

1 reference

2 December 2017

Christopher McGovern

3

1 reference

2 December 2017

Leo Fitzpatrick

4

1 reference

2 December 2017

Anuj Parikh

5

1 reference

2 December 2017

Nicholas Nilo

6

1 reference

2 December 2017

publication date

1 April 2008

1 reference

Journal of Immunotoxicology

2 December 2017

published in

1 reference

2 December 2017

volume

5

1 reference

2 December 2017

issue

2

1 reference

2 December 2017

page(s)

179-187

1 reference

Immune-derived opioids and peripheral antinociception

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F15476910802131469

Nuclear factor kappaB signaling in opioid functions and receptor gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15476910802131469

Cytokine-based therapies for Crohn's disease--new paradigms

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15476910802131469

Inhibition of the respiratory burst in mouse macrophages by ultra-low doses of an opioid peptide is consistent with a possible adaptation mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15476910802131469

The opioid antagonist naltrexone blocks acute endotoxic shock by inhibiting tumor necrosis factor-alpha production

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15476910802131469

Risks and benefits of combining immunosuppressives and biological agents in inflammatory bowel disease: is the synergy worth the risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15476910802131469

Absence of preproenkephalin increases the threshold for T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15476910802131469

A comparative study of immunomodulation produced by in vitro exposure to delta opioid receptor agonist peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15476910802131469

Stimulation of human peripheral lymphocytes by methionine enkephalin and delta-selective opioid analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15476910802131469

Antiexudative effects of opioids and expression of kappa- and delta-opioid receptors during intestinal inflammation in mice: involvement of nitric oxide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15476910802131469

Review article: biological drugs in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15476910802131469

Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15476910802131469

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15476910802131469

Angiotensin AT2 receptor protects against cerebral ischemia-induced neuronal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15476910802131469

Dextromethorphan protects dopaminergic neurons against inflammation-mediated degeneration through inhibition of microglial activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15476910802131469

Opioids, opioid receptors, and the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15476910802131469

Activation pattern of signal transducers and activators of transcription (STAT) factors in inflammatory bowel diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15476910802131469

Treatment of inflammatory bowel disease: safety and tolerability issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15476910802131469

Naltrexone and disulfiram in patients with alcohol dependence and current depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15476910802131469

Mu opioid receptor expression is increased in inflammatory bowel diseases: implications for homeostatic intestinal inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15476910802131469

Anti-inflammatory properties of the mu opioid receptor support its use in the treatment of colon inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15476910802131469

Cytokine therapy for Crohn's disease: advances in translational research

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15476910802131469

Mouse models for the study of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15476910802131469

Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15476910802131469

Biologic therapy of inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15476910802131469

Inflammatory bowel disease: past, present, and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15476910802131469

Low-dose naltrexone therapy improves active Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15476910802131469

The immunology of mucosal models of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15476910802131469

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15476910802131469

Mu and delta receptors mediate morphine effects on phagocytosis by murine peritoneal macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15476910802131469

Methionine-enkephalin stimulates hydrogen peroxide and nitric oxide production in rat peritoneal macrophages: interaction of mu, delta and kappa opioid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15476910802131469

A PCR primer bank for quantitative gene expression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15476910802131469

Enhanced survival and mucosal repair after dextran sodium sulfate-induced colitis in transgenic mice that overexpress growth hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15476910802131469

Activation of mouse T-helper cells induces abundant preproenkephalin mRNA synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15476910802131469

10.1080/15476910802131469

21 January 2018

Identifiers

DOI

1 reference

2 December 2017

1 reference